The use of macroporous microcarriers for the large-scale growth of V79 cells genetically designed to express single human cytochrome P450 isoenzymes and for the characterization of the expressed cytochrome P450

Protein Expression and Purification

Volumn 8, Issue 4, 1996, Pages 439-446

  Onderwater, Rob C A ^c   Goeptar, Arnold R ^c   Levering, Piet R ^a   Vos, Ria M E ^a   Konings, Pierre N M ^a   Doehmer, Johannes ^b   Commandeur, Jan N M ^c   Vermeulen, Nico P E ^c  

^a NV ORGANON   (Netherlands)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0030444331     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1006/prep.1996.0122     Document Type: Article

References (42)

1. 1. Cholerton, S., Daly, A. K. and Idle, J. R. (1992) The role of individual human cytochromes P450 in drug metabolism and clinical response. TIPS Rev. 13, 434-439.
2. 2. Gonzalez, F. J. (1992) Human cytochromes P450: Problems and prospects. TIPS 13, 346-352.
3. 3. Koymans, L., Donné-Op den Kelder, G. M., Te Koppele, J. M., and Vermeulen, N. P. E. (1993) Cytochromes P450: Their active-site structure and mechanism of action. Drug Metab. Rev. 25, 325-387.
4. 4. Nebert, D. W., Nelson, D. R., Coon, M. J., Estabrook, R. W., Feyereisen, R., Fujii-Kuriyama, Y., Gonzalez, F. J., Guengerich, F. P., Gunsalus, I. C., Johnson, E. F., Loper, J. C., Sato, R., Waterman, M. R., and Waxman, D. J. (1991) The P450 superfamily: Update on new sequences, gene mapping and recommended nomenclature. DNA Cell. Biol. 10, 1-14.
5. 5. Goeptar, A. R., Scheerens, H., and Vermeulen, N. P. E. (1995) Oxygen and xenobiotic reductase activities of cytochrome P450. Crit. Rev. Toxicol. 25, 25-65.
6. 6. Doehmer, J., Goeptar, A. R., and Vermeulen, N. P. E. (1993) Cytochromes P450 and drug resistance. Cytotechnology 12, 357-366.
7. 7. Guengerich, F. P. (1993) "Cytochromes P450" (Schenkman, J. B., and Greim, H., Eds.), pp. 89-103, Springer, Heidelberg.
8. 8. Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., and Guengerich, F. P. (1994) Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and caucasians. J. Pharmacol. Exp. Ther. 210, 414-423.
9. 9. Kawajiri, K., Nakachi, K., Imai, K., Watanabe, J., and Hayashi, S.-I. (1993) The CYP1A1 gene and cancer susceptibility. Crit. Rev. Oncol. Hematol. 14, 77-87.
10. 10. Drakoulis, N., Cascorbi, I., Brockmöller, J., Gross, C. R., and Roots, I. (1994) Polymorphisms in the human CYP1A1 gene as susceptibility factors for lung cancer: Exon-7 mutation (4889 A to G), and a T to C mutation in the 3′-flanking region. Clin. Invest. 72, 240-248.
11. 11. Sivaraman, L., Leatham, M. P., Yee, J., Wilkins, L. R., Lau, A. F., and Le Marchand, L. L. (1994) CYP1A1 genetic polymorphisms and in situ colorectal cancer. Cancer Res. 54, 3692-3695.
12. 12. Barnes, H. J., Jenkins, C. M., and Waterman, M. R. (1994) Baculovirus expression of bovine cytochrome P450c17 in Sf9 cells and comparison with expression in yeast, mammalian cells, and E. coli. Arch. Biochem. Biophys. 315, 489-494.
13. 13. Gillam, E. M. J., Baba, T., Kim, B.-R., Ohmori, S., and Guengerich, F. P. (1993) Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme. Arch. Biochem. Biophys. 305, 123-131.
14. 2-terminal region on localization in cytosol and membranes. Proc. Natl. Acad. Sci. USA 90, 2651-2655.
15. 15. Guo, Z., Gillam, E. M. J., Ohmori, S., Tukey, R. H., and Guengerich, F. P. (1994) Expression of modified cytochrome P450 1A1 in Escherichia coli: Effects of 5′ substitution, stabilization, purification, spectral characterization, and catalytic properties. Arch. Biochem. Biophys. 312, 436-446.
16. 16. Gillam, E. M. J., Guo, Z. Y., and Guengerich, F. P. (1994) Expression of modified human cytochrome P450 2E1 in Escherichia coli, purification, and spectral and catalytic properties. Arch. Biochem. Biophys. 312, 59-66.
17. 17. Karam, W. G., and Chiang, J. Y. L. (1994) Expression and purification of human cholesterol 7α-hydroxylase in Escherichia coli. J. Lipid Res. 35, 1222-1231.
18. 18. Sengstag, C., Eugster, H.-P., and Würgler, F. E. (1994) High promutagen activating capacity of yeast microsomes containing human cytochrome P-450 1A and human NADPH-cytochrome P-450 reductase. Carcinogenesis 15, 837-843.
19. 19. Glatt, H., and Gemperlein, J. (1987) Search for cell culture systems with diverse xenobiotic-metabolizing activities and their use in toxicological studies. Mol. Toxicol. 1, 313-334.
20. 20. Dogra, S., Doehmer, J., Glatt, H., Mölders, H., Siegert, P., Friedberg, T., Seidel, A., and Oesch, F. (1990) Stable expression of rat cytochrome P-450IA1 cDNA in V79 chinese hamster cells and their use in mutagenicity testing. Mol. Pharmacol. 37, 608-613.
21. 21. Doehmer, J., Dogra, S., Friedberg, T., Monier, S., Adesnik, M., Glatt, H., and Oesch, F. (1988) Stable expression of rat cytochrome P450 IIB1 cDNA in Chinese hamster cells (V79) and mutagenicity of aflatoxin B1. Proc. Natl. Acad. Sci. USA 85, 5769-5773.
22. 22. Schmalix, W. A., Barrenscheen, M., Landsiedel, R., Janzowski, C., Eisenbrand, G., Gonzalez, F., Eliasson, E., Ingelman-Sundberg, M., Perchermeier, M., Greim, H., and Doehmer, J. (1995) Stable expression of human cytochrome P450 2E1 in V79 Chinese hamster cells. Eur. J. Pharmacol. Environ. Toxicol. Sect. 293, 123-131.
23. 23. Hu, W.-S., and Piret, J. M. (1992) Mammalian cell culture processes. Current Op. Biotechnol. 3, 110-114.
24. 24. Reiter, M., and Blüml, G. (1994) Large-scale mammalian cell culture. Current Op. Biotechnol. 5, 175-179.
25. 25. Hopkinson, J. (1985) Hollow fiber cell culture systems for economical cell-product manufacturing. Bio / Technology 3, 225-230.
26. 26. Griffiths, J. B. (1992) Animal cell culture processes - batch or continuous? J. Biotechnol. 22, 21-30.
27. 27. Konings, P. N. M., Vanderheyden, P. M. L., Stam, N. J., Van Delft, A. M. L., and Ruigt, G. S. F. (1993) Use of a cloned G-protein-coupled receptor in the in vitro screening of psychotropic compounds. ATLA 21, 450-452.
28. 28. Doehmer, J., Seidel, A., Oesch, F., and Glatt, H. R. (1990) Genetically engineered V79 Chinese hamster cells metabolically activate the cytostatic drugs cyclophosphamide and ifosfamide. Environ. Health Perspect. 88, 63-65.
29. 29. Omura, T., and Sato, R. (1964) The carbon monoxide-binding pigment of liver microsomes. II. Solubilization, purification, and properties. J. Biol. Chem. 239, 2379-2385.
30. 30. Rutten, A. A. J. J. L., Falke, H. E., Catsburg, J. F., Topp, R., Blaauboer, B. J., van Holsteijn, I., Doorn, L., and van Leeuwen, F. X. R. (1987) Interlaboratory comparison of total cytochrome P-450 and protein determinations in rat liver microsomes. Arch. Toxicol. 61, 27-33.
31. 31. Omura, T., and Sato, R. (1964) The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem. 239, 2370-2378.
32. 32. Williams, C. H., and Kamin, H. (1962) Microsomal triphosphoridine nucleotide cytochrome c-reductase of liver. J. Biol. Chem. 237, 587-595.
33. 33. Burke, M. D., and Mayer, R. T. (1983) Differential effects of phenobarbitone and 3-methylcholanthrene induction on hepatic microsomal metabolism and cytochrome P-450-binding of phenoxazone and a homologous series of its n-alkyl ethers (alkoxyresorufins). Chem. Biol. Interact. 45, 243-258.
34. 34. Greenlee, W. F., and Poland, A. (1978) An improved assay of 7-ethoxycoumarin O-deethylase activity: Induction of hepatic enzyme activity in C57BL/6J and DBA/2J mice by phenobarbital, 3-methylcholanthrene and 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Pharmacol. Exp. Ther. 205, 597-605.
35. 35. Platt, K. L., Molitor, E., Doehmer, J., Dogra, S., and Oesch, F. (1989) Genetically engineered V79 Chinese hamster cell expression of purified cytochrome P-450IIB1 monooxygenase activity. J. Biochem. Toxicol. 4, 1-5.
36. 36. Van der Hoeven, T. (1981) Testosterone oxidation by rat liver microsomes: Effects of phenobarbital pretreatment and the detection of seven metabolites by HPLC. Biochem. Biophys. Res. Commun. 100, 1285-1291.
37. 37. Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
38. 38. Lopez Garcia, M. P., Dansette, P. M., Valadon, P., Amar, C., Beaune, P. H., Guengerich, F. P., and Mansuy, D. (1993) Human-liver cytochromes ∼P-450 expressed in yeast as tools for reactive-metabolite formation studies. Oxidative activation of tienilic acid by cytochromes P-450 2C9 and 2C10. Eur. J. Biochem. 213, 223-232.
39. 39. Kaminsky, L. S., Dunbar, D. A., Wang, P. P., Beaune, P. H., Larrey, D., Guengerich, F. P., Schnellmann, R. G., and Sipes, I. G. (1984) Human hepatic cytochrome P-450 composition as probed by in vitro microsomal metabolism of warfarin. Drug Metab. Dispos. 12, 470-477.
40. 40. Crespi, C. L., Penman, B. W., Gonzalez, F. J., Gelboin, H. V., Galvin, M., and Langenbach, R. (1993) Genetic toxicology using human cell lines expressing human P-450. P-450 Biotechnology 21, 1023-1028.
41. 41. Penman, B. W., Chen, L. P., Gelboin, H. V., Gonzalez, F. J., and Crespi, C. L. (1994) Development of a human lymphoblastoid cell line constitutively expressing human CYP1A1 cDNA: Substrate specificity with model substrates and promutagens. Carcinogenesis 15, 1931-1937.
42. 42. Schmalix, W. A., Mäser, H., Kiefer, F., Reen, R., Wiebel, F. J., Gonzalez, F. J., Seidel, A., Glatt, H., Greim, H., and Doehmer, J. (1993) Stable expression of human cytochrome P450 1A1 cDNA in V79 Chinese hamster cells and metabolic activation of benzo[a]pyrene. Eur. J. Pharmacol. Environ. Toxicol. Sect. 248, 251-261.